An Open-Label Extension to Protocol 09-1, Efficacy and Safety Study of the EndoBarrier® Gastrointestinal Liner System

NCT02293720 · clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped This was the cross over study for 09-1 which was terminated early

Conditions

Interventions

Sponsor

Morphic Medical Inc.